Table 2.
Characteristics of case reports/case series studies.
| First author | Country | Published time | Type of study | Number of patients with COVID-19 | Number of COVID-19 patients with HIV | Mean age | Male/female | Diagnostic method |
|---|---|---|---|---|---|---|---|---|
| Parker et al. (2020) | South Africa | 2020 | Case report | 1 | 1 | 41 | M | Real-time PCR |
| Baluku et al. (2022) | Uganda | 2020 | Case report | 1 | 1 | 34 | F | Real-time PCR |
| Elhadi et al. (2020) | Libya | 2020 | Case report | 1 | 1 | 86 | F | CT, Real-time PCR |
| Khaba et al. (2020) | South Africa | 2020 | Case report | 1 | 1 | 19 | M | Real-time PCR, HIV VL, CD4+ count |
| Bertolini et al. (2020) | Argentina | 2020 | Case report | 1 | 1 | 43 | M | Real-time PCR, DH |
| Modi et al. (2019) | USA | 2020 | Case report | 1 | 1 | 32 | M | PCR, HIV VL, CD4+ count |
| Cipolat and Sprinz (2020) | Brazil | 2020 | Case report | 1 | 1 | 63 | F | Real-time PCR |
| Haddad et al. (2020) | USA | 2020 | Case report | 1 | 1 | 41 | M | Real-time PCR, blood test; CT scan |
| Rivas et al. (2020) | Panama | 2020 | Case series | 2 | 2 | 41 | 2M | Chest radiography, Real-time PCR, CD4 count, VL, CT scan, GeneXpert |
| Suwanwongse and Shabarek (2020) | USA | 2020 | Case series | 9 | 9 | 58 | 7M/2F | Real-time PCR, CXR, HIV VL, CD4+ count |
| Przydzial et al. (2020) | USA | 2020 | Case series | 2 | 2 | 57 | 2M | Real-time PCR, CXR, CT scan, blood test, HIV VL, CD4 count |
| Benkovic et al. (2020) | USA | 2020 | Case series | 4 | 4 | 59.75 | 4M | Real-time PCR, CXR, CD4 count |
| Pata et al. (2020) | USA | 2020 | Case series | 3 | 3 | 50.3 | 2M/F | Real-time PCR, CXR, CT scan, blood test |
| Farias et al. (2020) | Brazil | 2020 | Case series | 2 | 2 | 41 | 2M | CT-scan Real-time PCR, blood tests, PCR |
| Ridgway et al. (2020) | USA | 2020 | Case series | 5 | 5 | 48 | M/4F | PCR, CXR, CT-scan, CD4 count, blood testing |
| Chiappe Gonzalez et al. (2020) | Peru | 2020 | Case report | 1 | 1 | 38 | M | Real-time PCR, CT-scan; blood test; CD4 Count |
| Mahmood et al. (2020) | USA | 2020 | Case report | 1 | 1 | NR | M | CT |
| Byrd et al. (2020) | USA | 2020 | Case series | 9 | 9 | 55 | 7M/F/TSF | PCR, CT |
| Patel (2020) | USA | 2020 | Case report | 1 | 1 | 58 | M | Real-time PCR, CD4 count |
| Zhao et al. (2020) | China | 2020 | Case report | 1 | 1 | 38 | M | Serology, Real-time PCR |
| Zhang et al. (2020b) | China | 2020 | Case series | 2 | 2 | 30.5 | 2M | Blood test, CT-scan, Real-time PCR, serology |
| Rahbarnia et al. (2020) | Singapore | 2020 | Case series | 2 | 2 | 45 | 2M | Real-time PCR, CXR |
| Ruan et al. (2021) | China | 2020 | Case series | 4 | 4 | `40.75 | 4M | Real-time PCR, chest CT-scan, CD4 count, blood tests |
| Janakiram Marimuthu and Gandhi (n.d.) | South India | 2020 | Case series | 6 | 6 | 38 | 3M/2F/TSF | Real-time PCR, CT-scan; CXR, blood test |
| Adachi et al. (2020) | Japan | 2020 | Case series | 2 | 2 | 41.5 | 2TSF | Real-time PCR, CT-scan, blood test,CXR |
| Li et al. (2020b) | China | 2020 | Case report | 1 | 1 | 24 | M | CT, PCR, serology |
| Wu et al. (2020) | China | 2020 | Case report | 1 | 1 | 47 | M | CT |
| Nakamoto et al. (2020) | Japan | 2020 | Case report | 1 | 1 | 28 | M | Blood testing, CT-scan, Real-time PCR |
| Sun et al. (2020) | Singapore | 2020 | Case report | 1 | 1 | 37 | M | Chest radiogeraph, Real-time PCR, CD4+ count |
| Li et al. (2020b) | China | 2020 | Case report | 1 | 1 | 37 | M | CT, PCR, serology |
| Chen et al. (2020c) | China | 2020 | Case report | 1 | 1 | 24 | M | Real-time PCR, CT-scan |
| Zhu et al. (2020a) | China | 2020 | Case report | 1 | 1 | 61 | M | Real-time PCR, CT-scan, blood test |
| Wang et al. (2020b) | China | 2020 | Case report | 1 | 1 | 37 | M | Real-time PCR, CD4 count, CT-scan,serology,blood tests |
| Wu et al. (2020) | China | 2020 | Case report | 1 | 1 | 60 | M | CT, Real-time PCR |
| Zhu et al. (2020b) | China | 2020 | Case report | 1 | 1 | NR | NR | Real-time PCR |
| Tian et al. (2020) | China | 2020 | Case report | 1 | 1 | 24 | M | CT-scan, Real-time PCR, blood tests |
| Ciccullo et al. (2020) | Italy | 2020 | Case series | 4 | 2 | 27.5 | 2M | Real-time PCR, CT |
| Bartilotti Matos and Davies (2021) | UK | 2020 | Case report | 1 | 1 | 51 | M | CT, PCR |
| Di Giambenedetto et al. (2020) | Italy | 2020 | Case report | 1 | 1 | 75 | M | Real-time PCR, CXR |
| Riva et al. (2020) | Italy | 2020 | Case series | 3 | 3 | 60.6 | 2M/F | Real-time PCR, CXR |
| Aydin et al. (2020) | Turkey | 2020 | Case series | 4 | 4 | 37.25 | 4M | Real-time PCR, CT-scan, serology |
| Toombs et al. (2020) | UK | 2020 | Case series | 3 | 3 | 55 | 2M/F | CXR, blood tests, CD4 count, Real-time PCR |
| Sasset et al. (2020) | Italy | 2020 | Case series | 2 | 2 | 61.5 | 2M | Real-time PCR, chest radiograph, blood tests, HIV VL, CD4+ count |
| Bartilotti Matos and Davies (2021) | UK | 2020 | Case report | 1 | 1 | 38 | M | CT, PCR |
| d’Ettorre et al. (2020) | Italy | 2020 | Case report | 1 | 1 | 52 | F | Real-time PCR, CT-scan, blood test |
| Farinacci et al. (2020) | Italy | 2020 | Case report | 1 | 1 | 59 | M | PCR, CT |
| Coleman et al. (2020) | UK | 2020 | Case report | 1 | 1 | 55 | M | Multiplex PCR, Real-time PCR, CT-scan, |
| Iordanou et al. (2020) | Cyprus | 2020 | Case report | 1 | 1 | 58 | M | Real-time PCR |
| Molina-Iturritza et al. (2020) | Spain | 2020 | Case series | 8 | 8 | 47.5 | 7M/F | Real-time PCR |
| Pinnetti et al. (2020) | Italy | 2020 | Case report | 1 | 1 | 55 | NR | Real-time PCR, IFA, chest HRTC |
| Di Biagio et al. (2020) | Italy | 2020 | Case series | 4 | 4 | 65 | 3M/1F | CT |
| Joumaa et al. (2020) | France | 2020 | Case report | 1 | 1 | 65 | M | CT, Real-time PCR, VL, CD4 count |
| Pinnetti et al. (2020) | Italy | 2020 | Case report | 1 | 1 | 32 | NR | Chest HRTC, PCR, IFA |
TSF; Trans Female, PCR; Polymerase Chain Reaction, HRCT; High-resolution computed tomography, VL; Viral Load, CXR; Chest X-Ray, ELISA; Enzyme-Linked Immunosorbent Assay, IFA; Immunofluorescence assay, NR; not report.